491: Darifenacin, an M3 Selective Receptor Antagonist, Reduces the Frequency of Nocturnal Awakening, an Important Symptom of Overactive Bladder

Abstract

You have accessJournal of UrologyPodium, Sunday, May 9, 2004, 10:00 am - 12:00 pm1 Apr 2004491: Darifenacin, an M3 Selective Receptor Antagonist, Reduces the Frequency of Nocturnal Awakening, an Important Symptom of Overactive Bladder Vikram Khullar Vikram KhullarVikram Khullar More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)37753-XAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "491: Darifenacin, an M3 Selective Receptor Antagonist, Reduces the Frequency of Nocturnal Awakening, an Important Symptom of Overactive Bladder." The Journal of Urology, 171(4S), p. 131 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 171Issue 4SApril 2004Page: 131 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Vikram Khullar More articles by this author Expand All Advertisement PDF downloadLoading ...